Page 58 - SaxoCell Annual Report 2021
P. 58
SaxoCell OMICS
The SaxoCell OMICS platform ensures optimal and early support for the development
and production of gene and cell therapeutics within the Cluster. Therefore, SaxoCell
OMICS pursues four strategic goals for the cluster:
The provision of efficient and harmonized
SaxoCell Platforms processes for monitoring the delivery and
tolerability of novel therapies
The identification of mechanisms of
action, novel targets and resistance
Prof. Dr. Ezio Bonifacio
CRTD, TU Dresden
The development of improved quality
criteria for the manufacturing process
The development of predictive biomarkers
SaxoCell OMICS' collaboration with SaxoCell projects and Dr. Kristin Reiche
platforms enhances the competitiveness of biotechnology Fraunhofer IZI
and bioanalytical companies in the SaxoCell region.
53
